NCT05549908View on ClinicalTrials.gov

Vaccine Prevention of Rabies Adopts 4-shot Immunization Method

PHASE3CompletedINTERVENTIONAL
Enrollment

1,800

Participants

Timeline

Start Date

July 22, 2020

Primary Completion Date

October 31, 2021

Study Completion Date

April 20, 2023

Conditions
Rabies HumanAntibody Titer
Interventions
BIOLOGICAL

rabies vaccine

The subjects were vaccinated with rabies vaccines with different immunization procedures, and the safety and immunogenicity were compared

Trial Locations (1)

130000

Changchun Zhuoyi Biological Co., Ltd, Changchun

All Listed Sponsors
lead

Changchun Zhuoyi Biological Co., Ltd

OTHER

NCT05549908 - Vaccine Prevention of Rabies Adopts 4-shot Immunization Method | Biotech Hunter | Biotech Hunter